Facetten
Zugriff
Einrichtung
Medientyp
- Text 10
Karte
Erscheinungsjahr
Autor/in
- Paul, Carle
- Reich, Kristian 7
- Augustin, Matthias 4
- Lebwohl, Mark 4
- Blauvelt, Andrew 3
- alle zeigen
Sprache
- Englisch 10
10 Einträge gefunden
-
Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study
- Blauvelt, Andrew
- Armstrong, April W
- Langley, Richard G
- Gebauer, Kurt
- Thaçi, Diamant
- Bagel, Jerry
- Guenther, Lyn C
-
Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey
- Lebwohl, Mark
- Langley, Richard G
- Paul, Carle
- Puíg, Lluis
- Reich, Kristian
- van de Kerkhof, Peter
- Wu, Hsiuan-Lin
-
Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4)
- Bieber, Thomas
- Reich, Kristian
- Paul, Carle
- Tsunemi, Yuichiro
- Augustin, Matthias
- Lacour, Jean-Philippe
- Ghislain, Pierre-Dominique
-
Unmet medical needs in the treatment of atopic dermatitis in infants: An Expert consensus on safety and efficacy of pimecrolimus
- Luger, Thomas
- Augustin, Matthias
- Lambert, Julien
- Paul, Carle
- Pincelli, Carlo
- Torrelo, Antonio
- Vestergaard, Christian
-
Bimekizumab versus Secukinumab in Plaque Psoriasis
- Reich, Kristian
- Warren, Richard B
- Lebwohl, Mark
- Gooderham, Melinda
- Strober, Bruce
- Langley, Richard G
- Paul, Carle
-
Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL)
- Lacour, Jean-Philippe
- Bewley, Anthony
- Hammond, Edward
- Hansen, Jes B
- Horne, Laura
- Paul, Carle
- Reich, Kristian
-
Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis
- Langley, Richard G B
- Reich, Kristian
- Strand, Vibeke
- Feldman, Steven R
- Paul, Carle
- Gordon, Kenneth
- Warren, Richard B
-
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure
- Armstrong, April
- Paul, Carle
- Puig, Luis
- Boehncke, Wolf Henning
- Freeman, Michael
- Torii, Hideshi
- Papp, Kim
-
Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: Results Through 48 Weeks of a Phase 3, Multicenter, Randomized, Double-Blinded, Etanercept- and Placebo-Controlled Study (CIMPACT)
- Lebwohl, Mark
- Blauvelt, Andrew
- Paul, Carle
- Sofen, Howard
- Węgłowska, Jolanta
- Piguet, Vincent
- Burge, Daniel
-
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
- Griffiths, Christopher E M
- Reich, Kristian
- Lebwohl, Mark
- van de Kerkhof, Peter
- Paul, Carle
- Menter, Alan
- Cameron, Gregory S